Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105524100B analysis reveals safer vinyl potassium trifluoborate production. Eliminating ultra-low temperatures reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers significantly.
Patent CN113999166B details a novel Negishi coupling route for Tenibulin, offering milder conditions and higher yields for cost-effective API manufacturing.
Patent CN110938107B reveals a low-temp alkylation route for fulvestrant intermediates, offering high purity and cost reduction in pharmaceutical manufacturing.
Patent CN104328152A details high-yield biocatalytic synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN108586350A reveals metal-free tandem cyclization for high-purity imidazole-2-thiones. Offers substantial cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN112645854B details a novel purification method for Apremilast intermediates using PEG-modified catalysts and specific solvent systems to achieve over 99.5% purity.
Patent CN103420870A details a novel carbonylation route for high-purity chiral 4-cyano-3-hydroxybutyrate, offering significant cost reduction and scalable manufacturing for statin intermediates.
Advanced manufacturing of L-Phenylephrine HCl using optimized Rh-catalysis for high purity and cost-effective supply chain solutions.
Novel preparation method for Canagliflozin intermediates ensures high purity and yield. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Patent CN106831522A reveals Pd-catalyzed C-H activation for lactam synthesis. Enables cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Novel synthesis of Roxadustat intermediate via m-bromobenzaldehyde. High yield, eco-friendly process suitable for industrial scale-up and cost reduction.
Patent CN116120427B reveals high-yield solid-phase synthesis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN103687489A reveals a safer, scalable route for 5-azaspiro[2.4]heptane-6-carboxylic acid, eliminating pyrophoric reagents for reliable HCV inhibitor supply.
Patent CN102344351B reveals a novel biaryl chalcone synthesis with V-shaped conformation for superior antitumor activity. Discover scalable routes and cost-effective manufacturing strategies.
Patent CN115260153B reveals high-yield synthesis for EGFR inhibitors. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101098880B reveals improved yield and purity for 13-deoxyanthracyclines reducing cardiotoxicity risks via novel reduction methods.
Novel acid-catalyzed one-pot synthesis patent CN106883152A offers high yield and atom economy for reliable pharmaceutical intermediate supply chains.
Novel catalytic route for posaconazole reduces impurities and cost. Reliable supply chain partner for high-purity antifungal API manufacturing.
Patent CN113831330B reveals a green three-step synthesis route for alpha-glucosidase inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.